3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
5
Recruiting
2
Completed
2
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
49
Rectal Neoplasms
32
Pancreatic Neoplasms
28
Colonic Neoplasms
24
Stomach Neoplasms
19
Neoplasm Metastasis
15
Neoplasms
13
Esophageal Neoplasms
10
Breast Neoplasms
7
Head and Neck Neoplasms
6
Recurrence
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Adenocarcinoma Of Esophagus
5
Lymphoma, Large B-Cell, Diffuse
4
Carcinoma, Hepatocellular
4
Ovarian Neoplasms
3
Lymphoma, Extranodal NK-T-Cell
3
Liver Neoplasms
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Adenocarcinoma
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peritoneal Neoplasms
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Interventions
Capecitabine
3
Fluorouracil
2
Cetuximab
2
Bevacizumab
2
aflibercept
1
Panitumumab
1
Oxaliplatin
1
Nivolumab
1
Methotrexate
1
Leucovorin
1
Hypnosis
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Colorectal Cancer Metastatic
×
Oxaliplatin
×
Clear all
NCT01955629
2016-04-18
AMOR
Sanofi
Phase 1/2
Terminated
4 enrolled
7 charts